News & Events
Ivantis Announces HYDRUS II Glaucoma Study Met Primary Endpoint In a Randomized Controlled Trial
24 / 10 / 2014
Celladon Corporation Secures $25 Million Credit Facility from Hercules Growth Capital
01 / 08 / 2014
Spinifex Pharmaceuticals Appoints Neuroscience Expert Dr Ronald Marcus as Chief Medical Officer
03 / 06 / 2014
Celladon Corporation Appoints Paul Cleveland as President and Chief Financial Officer
03 / 06 / 2014
Spinifex Pharmaceuticals Strengthens Scientific Advisory Board (SAB) with Experts in Chronic Pain
27 / 05 / 2014
Sunshine Heart Announces Presentations at the Annual Meeting of the Heart Failure Association
14 / 05 / 2014
PLC Systems Proposes Series of Business Transactions Designed to Preserve Value for Shareholders
14 / 05 / 2014
FDA Approves Teva SYNRIBO® (Omacetaxine Mepesuccinate) for Injection for Home Administration
07 / 05 / 2014
Displaying records 176-200 of 705